CD40LG and Alzheimer disease: Furthermore, genetic ablation of CD40L or administration of a CD40L-neutralizing antibody markedly reduces amyloid plaques in mouse models of AD, effects that are associated with mitigated astrocytosis and microgliosis ([75], for review see [76,77]).